Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey
Tomoyuki Suzuki, Yoshihiro Kita, Keisuke Yanagida, Kenji Maeda, Tomomi Hashidate‐Yoshida, Hiroki Nakanishi, Takayo Ohto‐Nakanishi, Junko Terada-Hirashima, Yoshie Tsujimoto, Masayuki Hojo, Hiroaki Mitsuya, Takao Shimizu, Hideo Shindou
The paper identifies a molecular signature in early-stage COVID-19 patients that predicts disease exacerbation using multi-omics analysis of plasma samples.
PLoS ONE · Jul 22, 2026Peer-reviewedMicrobiology